نتائج البحث

تحتوي على الكلمات

فقط من النوع

Assuring to unify the information of the AR person in both NCMDR and MDNR التعاميم

26th GHWP Annual Meeting and 26th TC Meeting مقال

A FARAPULSE Pulsed Field Ablation ProspectiVE RegiStry in REal Life Utilization (PF115),Sub-Study: FARAWAY: The FARAPULSE Workflow Assessment Registry (PF117) قائمة دراسات سريرية

Post-Market Evaluation for the Safety of Ventilator Associated Pneumonia in the Intensive Care Unit دراسات الأجهزة الطبية

A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF 06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE قائمة الدراسات السريرية المسجلة على الادوية

An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension قائمة الدراسات السريرية المسجلة على الادوية

سحب جميع التشغيلات من مستحضري (of MIMPARA 30MG F.C. TABLETS) و (MIMPARA 60MG F.C. TABLETS) السحب و الإستدعاءات

سحب عدة تشغيلات من مستحضر (‎CHAMPIX 0.5 MG &1 MG F-C TABLETS) (CHAMPIX 1MG F-C TABLETS) من إنتاج شركة (R-PHARM GERMANY GMBH) السحب و الإستدعاءات

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of brigimadlin (BI 907828) for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours قائمة الدراسات السريرية المسجلة على الادوية

"Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection" قائمة الدراسات السريرية المسجلة على الادوية